Author: Liu, Hong Yan; Gao, Xiaohu
Title: A Universal Protein Tag for Delivery of SiRNA-Aptamer Chimeras Document date: 2013_11_7
ID: 0atfsivf_9
Snippet: Design, synthesis, and characterization of siRNA-aptamer chimera. To evaluate the universal protein tag for siRNA-aptamer chimera, we first designed and made a chimera based on the protocols described by Dassie and coworkers, taking advantage of the shortened aptamer sequence for specific targeting of PSMA as well as the optimized siRNA strands with enhanced therapeutic potency 15 . The PSMA targeting aptamer was kept in our chimera, because PSMA.....
Document: Design, synthesis, and characterization of siRNA-aptamer chimera. To evaluate the universal protein tag for siRNA-aptamer chimera, we first designed and made a chimera based on the protocols described by Dassie and coworkers, taking advantage of the shortened aptamer sequence for specific targeting of PSMA as well as the optimized siRNA strands with enhanced therapeutic potency 15 . The PSMA targeting aptamer was kept in our chimera, because PSMA has been identified as one of the most attractive cell surface markers for both prostate epithelial cells and neovascular endothelial cells 36 . Accumulation and retention of PSMA targeting probes at the site of tumor growth is the basis of radioimmunoscintigraphic scanning (e.g., ProstaScint scan) and targeted therapy for human prostate cancer metastasis. We replaced their siRNA sequence with a siRNA silencing GFP expression, because GFP is the best model for quantitative assessment of the silencing effect using optical imaging and flow cytometry.
Search related documents:
Co phrase search for related documents- cell surface and epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cell surface and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cell surface and flow cytometry optical imaging: 1
- cell surface and gfp expression: 1, 2, 3, 4
- cell surface and good model: 1
- cell surface and human prostate: 1, 2, 3
- cell surface and optical imaging: 1
- cell surface and probe targeting: 1
- cell surface and quantitative assessment: 1
- cell surface and specific targeting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- cell surface and therapeutic potency: 1, 2
- cell surface and tumor growth: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cell surface and tumor growth site: 1
- cell surface marker and endothelial cell: 1, 2, 3
- cell surface marker and flow cytometry: 1, 2
- cell surface marker and specific targeting: 1
- characterization synthesis and gfp expression: 1
- characterization synthesis and optical imaging: 1
Co phrase search for related documents, hyperlinks ordered by date